Patients with EAS will have a ratio less than 2 before and after CRH administration because the endogenous hypercortisolism suppresses pituitary ACTH release through negative feedback mechanisms (sensitivity 97%, specificity 100%). Here, CRH is linked to adrenal gland hyperfunction.